annual EBITDA:
$67.51M+$132.92M(+203.21%)Summary
- As of today (May 29, 2025), CLBT annual EBITDA is $67.51 million, with the most recent change of +$132.92 million (+203.21%) on December 31, 2024.
- During the last 3 years, CLBT annual EBITDA has fallen by -$21.95 million (-24.54%).
- CLBT annual EBITDA is now -48.11% below its all-time high of $130.10 million, reached on December 31, 2022.
Performance
CLBT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$14.90M-$3.56M(-19.27%)Summary
- As of today (May 29, 2025), CLBT quarterly EBITDA is $14.90 million, with the most recent change of -$3.56 million (-19.27%) on March 1, 2025.
- Over the past year, CLBT quarterly EBITDA has increased by +$2.97 million (+24.92%).
- CLBT quarterly EBITDA is now -80.05% below its all-time high of $74.67 million, reached on December 31, 2021.
Performance
CLBT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$42.57M+$2.97M(+6.53%)Summary
- As of today (May 29, 2025), CLBT TTM EBITDA is -$42.57 million, with the most recent change of +$2.97 million (+6.53%) on March 1, 2025.
- Over the past year, CLBT TTM EBITDA has dropped by -$95.16 million (-180.95%).
- CLBT TTM EBITDA is now -147.58% below its all-time high of $89.47 million, reached on December 31, 2021.
Performance
CLBT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLBT EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +203.2% | +24.9% | -180.9% |
3 y3 years | -24.5% | +8875.3% | -150.8% |
5 y5 years | +1100.4% | +369.9% | -1442.5% |
CLBT EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -48.1% | +203.2% | -32.5% | +115.2% | -150.8% | +19.1% |
5 y | 5-year | -48.1% | +203.2% | -80.0% | +115.2% | -147.6% | +19.1% |
alltime | all time | -48.1% | +203.2% | -80.0% | +115.2% | -147.6% | +19.1% |
CLBT EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $14.90M(-19.3%) | -$42.57M(-6.5%) |
Dec 2024 | $67.51M(-203.2%) | $18.46M(-16.4%) | -$45.54M(-1.8%) |
Sep 2024 | - | $22.07M(-122.5%) | -$46.39M(-11.8%) |
Jun 2024 | - | -$97.99M(-921.6%) | -$52.59M(-200.0%) |
Mar 2024 | - | $11.93M(-32.3%) | $52.59M(+21.6%) |
Dec 2023 | -$65.41M(-150.3%) | $17.61M(+11.1%) | $43.25M(+14.3%) |
Sep 2023 | - | $15.86M(+120.5%) | $37.83M(+63.1%) |
Jun 2023 | - | $7.19M(+178.4%) | $23.19M(+83.2%) |
Mar 2023 | - | $2.58M(-78.8%) | $12.65M(+23.6%) |
Dec 2022 | $130.10M | $12.19M(+899.5%) | $10.24M(-85.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | $1.22M(-136.5%) | $72.72M(+3.1%) |
Jun 2022 | - | -$3.34M(-2113.3%) | $70.50M(-15.8%) |
Mar 2022 | - | $166.00K(-99.8%) | $83.76M(-6.4%) |
Dec 2021 | $89.47M(+417.9%) | $74.67M(-7604.7%) | $89.47M(+279.5%) |
Sep 2021 | - | -$995.00K(-110.0%) | $23.57M(-33.1%) |
Jun 2021 | - | $9.92M(+69.0%) | $35.24M(+23.7%) |
Mar 2021 | - | $5.87M(-33.2%) | $28.49M(+25.9%) |
Dec 2020 | $17.28M(+207.2%) | $8.78M(-17.7%) | $22.62M(+63.4%) |
Sep 2020 | - | $10.67M(+236.5%) | $13.84M(+336.5%) |
Jun 2020 | - | $3.17M | $3.17M |
Dec 2019 | $5.62M | - | - |
FAQ
- What is Cellebrite DI annual EBITDA?
- What is the all time high annual EBITDA for Cellebrite DI?
- What is Cellebrite DI annual EBITDA year-on-year change?
- What is Cellebrite DI quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cellebrite DI?
- What is Cellebrite DI quarterly EBITDA year-on-year change?
- What is Cellebrite DI TTM EBITDA?
- What is the all time high TTM EBITDA for Cellebrite DI?
- What is Cellebrite DI TTM EBITDA year-on-year change?
What is Cellebrite DI annual EBITDA?
The current annual EBITDA of CLBT is $67.51M
What is the all time high annual EBITDA for Cellebrite DI?
Cellebrite DI all-time high annual EBITDA is $130.10M
What is Cellebrite DI annual EBITDA year-on-year change?
Over the past year, CLBT annual EBITDA has changed by +$132.92M (+203.21%)
What is Cellebrite DI quarterly EBITDA?
The current quarterly EBITDA of CLBT is $14.90M
What is the all time high quarterly EBITDA for Cellebrite DI?
Cellebrite DI all-time high quarterly EBITDA is $74.67M
What is Cellebrite DI quarterly EBITDA year-on-year change?
Over the past year, CLBT quarterly EBITDA has changed by +$2.97M (+24.92%)
What is Cellebrite DI TTM EBITDA?
The current TTM EBITDA of CLBT is -$42.57M
What is the all time high TTM EBITDA for Cellebrite DI?
Cellebrite DI all-time high TTM EBITDA is $89.47M
What is Cellebrite DI TTM EBITDA year-on-year change?
Over the past year, CLBT TTM EBITDA has changed by -$95.16M (-180.95%)